Sanofi, Lifera and Arabio sign MOU to manufacture vaccines in Saudi Arabia

Lifera, a biopharmaceutical company in Saudi Arabia, together with Sanofi, and Arabio announced the signing of a Memorandum of Understanding, or MOU, which aims to strengthen local manufacturing of vaccines in Saudi Arabia. Under the terms of the MOU, Lifera, Sanofi and Arabio will explore opportunities for collaboration to help advance Saudi Arabia’s vaccines localization strategy through a range of proposed initiatives that include Lifera being a contract manufacturer to Sanofi, through state-of-the-art manufacturing facilities and capabilities, as well as leveraging Arabio and Tamer Group’s, local and regional distribution strength in vaccines and other key pharmaceutical products.